2-[4-chloro-2,6-di(propan-2-yl)phenyl]-N-[1-ethyl-5-(3-methoxyoxetan-3-yl)pyrazol-3-yl]sulfonylacetamide;N-[1-ethyl-5-(3-methoxyoxetan-3-yl)pyrazol-3-yl]sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;2-(7-fluoro-5-pyridin-4-yl-2,3-dihydro-1H-inden-4-yl)-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide;2-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide;N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonyl-2-[5-(2-methyl-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]acetamide

C123H156ClF2N17O25S5 — CID 157475258

IUPAC2-[4-chloro-2,6-di(propan-2-yl)phenyl]-N-[1-ethyl-5-(3-methoxyoxetan-3-yl)pyrazol-3-yl]sulfonylacetamide;N-[1-ethyl-5-(3-methoxyoxetan-3-yl)pyrazol-3-yl]sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;2-(7-fluoro-5-pyridin-4-yl-2,3-dihydro-1H-inden-4-yl)-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide;2-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide;N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonyl-2-[5-(2-methyl-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]acetamide
SMILESCCn1nc(S(=O)(=O)NC(=O)Cc2c(C(C)C)cc(Cl)cc2C(C)C)cc1C1(OC)COC1.CCn1nc(S(=O)(=O)NC(=O)Cc2c(C(C)C)cc(F)cc2C(C)C)cc1C1(OC)COC1.COC1(c2cc(S(=O)(=O)NC(=O)Cc3c(-c4ccnc(C)c4)ccc4c3CCC4)nn2C(C)C)COC1.COC1(c2cc(S(=O)(=O)NC(=O)Cc3c(-c4ccncc4)cc(F)c4c3CCC4)nn2C(C)C)COC1.COC1(c2cc(S(=O)(=O)NC(=O)Cc3c4c(cc5c3CCC5)CCC4)nn2C(C)C)COC1
InChIInChI=1S/C27H32N4O5S.C26H29FN4O5S.C24H31N3O5S.C23H32ClN3O5S.C23H32FN3O5S/c1-17(2)31-24(27(35-4)15-36-16-27)14-26(29-31)37(33,34)30-25(32)13-23-21-7-5-6-19(21)8-9-22(23)20-10-11-28-18(3)12-20;1-16(2)31-23(26(35-3)14-36-15-26)13-25(29-31)37(33,34)30-24(32)12-21-18-5-4-6-19(18)22(27)11-20(21)17-7-9-28-10-8-17;1-15(2)27-21(24(31-3)13-32-14-24)12-23(25-27)33(29,30)26-22(28)11-20-18-8-4-6-16(18)10-17-7-5-9-19(17)20;2*1-7-27-20(23(31-6)12-32-13-23)11-22(25-27)33(29,30)26-21(28)10-19-17(14(2)3)8-16(24)9-18(19)15(4)5/h8-12,14,17H,5-7,13,15-16H2,1-4H3,(H,30,32);7-11,13,16H,4-6,12,14-15H2,1-3H3,(H,30,32);10,12,15H,4-9,11,13-14H2,1-3H3,(H,26,28);2*8-9,11,14-15H,7,10,12-13H2,1-6H3,(H,26,28)
InChIKeyBVMYKUXPEOFVAK-UHFFFAOYSA-N
MW2506.48 g/mol
LogP15.61
Rot. Bonds41

About 2-[4-chloro-2,6-di(propan-2-yl)phenyl]-N-[1-ethyl-5-(3-methoxyoxetan-3-yl)pyrazol-3-yl]sulfonylacetamide;N-[1-ethyl-5-(3-methoxyoxetan-3-yl)pyrazol-3-yl]sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;2-(7-fluoro-5-pyridin-4-yl-2,3-dihydro-1H-inden-4-yl)-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide;2-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide;N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonyl-2-[5-(2-methyl-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]acetamide

2-[4-chloro-2,6-di(propan-2-yl)phenyl]-N-[1-ethyl-5-(3-methoxyoxetan-3-yl)pyrazol-3-yl]sulfonylacetamide;N-[1-ethyl-5-(3-methoxyoxetan-3-yl)pyrazol-3-yl]sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;2-(7-fluoro-5-pyridin-4-yl-2,3-dihydro-1H-inden-4-yl)-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide;2-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide;N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonyl-2-[5-(2-methyl-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]acetamide (PubChem CID 157475258) has the molecular formula C123H156ClF2N17O25S5 and a molecular weight of 2506.48 g/mol. Its IUPAC name is 2-[4-chloro-2,6-di(propan-2-yl)phenyl]-N-[1-ethyl-5-(3-methoxyoxetan-3-yl)pyrazol-3-yl]sulfonylacetamide;N-[1-ethyl-5-(3-methoxyoxetan-3-yl)pyrazol-3-yl]sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;2-(7-fluoro-5-pyridin-4-yl-2,3-dihydro-1H-inden-4-yl)-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide;2-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide;N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonyl-2-[5-(2-methyl-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]acetamide.

Molecular Properties

Compound Name2-[4-chloro-2,6-di(propan-2-yl)phenyl]-N-[1-ethyl-5-(3-methoxyoxetan-3-yl)pyrazol-3-yl]sulfonylacetamide;N-[1-ethyl-5-(3-methoxyoxetan-3-yl)pyrazol-3-yl]sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;2-(7-fluoro-5-pyridin-4-yl-2,3-dihydro-1H-inden-4-yl)-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide;2-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide;N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonyl-2-[5-(2-methyl-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]acetamide
PubChem CID157475258
Molecular FormulaC123H156ClF2N17O25S5
Molecular Weight2506.48 g/mol
Exact Mass2503.97
IUPAC Name2-[4-chloro-2,6-di(propan-2-yl)phenyl]-N-[1-ethyl-5-(3-methoxyoxetan-3-yl)pyrazol-3-yl]sulfonylacetamide;N-[1-ethyl-5-(3-methoxyoxetan-3-yl)pyrazol-3-yl]sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;2-(7-fluoro-5-pyridin-4-yl-2,3-dihydro-1H-inden-4-yl)-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide;2-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide;N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonyl-2-[5-(2-methyl-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]acetamide
SMILESCCn1nc(S(=O)(=O)NC(=O)Cc2c(C(C)C)cc(Cl)cc2C(C)C)cc1C1(OC)COC1.CCn1nc(S(=O)(=O)NC(=O)Cc2c(C(C)C)cc(F)cc2C(C)C)cc1C1(OC)COC1.COC1(c2cc(S(=O)(=O)NC(=O)Cc3c(-c4ccnc(C)c4)ccc4c3CCC4)nn2C(C)C)COC1.COC1(c2cc(S(=O)(=O)NC(=O)Cc3c(-c4ccncc4)cc(F)c4c3CCC4)nn2C(C)C)COC1.COC1(c2cc(S(=O)(=O)NC(=O)Cc3c4c(cc5c3CCC5)CCC4)nn2C(C)C)COC1
InChIInChI=1S/C27H32N4O5S.C26H29FN4O5S.C24H31N3O5S.C23H32ClN3O5S.C23H32FN3O5S/c1-17(2)31-24(27(35-4)15-36-16-27)14-26(29-31)37(33,34)30-25(32)13-23-21-7-5-6-19(21)8-9-22(23)20-10-11-28-18(3)12-20;1-16(2)31-23(26(35-3)14-36-15-26)13-25(29-31)37(33,34)30-24(32)12-21-18-5-4-6-19(18)22(27)11-20(21)17-7-9-28-10-8-17;1-15(2)27-21(24(31-3)13-32-14-24)12-23(25-27)33(29,30)26-22(28)11-20-18-8-4-6-16(18)10-17-7-5-9-19(17)20;2*1-7-27-20(23(31-6)12-32-13-23)11-22(25-27)33(29,30)26-21(28)10-19-17(14(2)3)8-16(24)9-18(19)15(4)5/h8-12,14,17H,5-7,13,15-16H2,1-4H3,(H,30,32);7-11,13,16H,4-6,12,14-15H2,1-3H3,(H,30,32);10,12,15H,4-9,11,13-14H2,1-3H3,(H,26,28);2*8-9,11,14-15H,7,10,12-13H2,1-6H3,(H,26,28)
InChIKeyBVMYKUXPEOFVAK-UHFFFAOYSA-N
XLogP15.61
TPSA523.38 Ų
H-Bond Donors5
H-Bond Acceptors37
Rotatable Bonds41
Heavy Atoms173
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002506.48
LogP ≤ 515.61
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1037

Analyze 2-[4-chloro-2,6-di(propan-2-yl)phenyl]-N-[1-ethyl-5-(3-methoxyoxetan-3-yl)pyrazol-3-yl]sulfonylacetamide;N-[1-ethyl-5-(3-methoxyoxetan-3-yl)pyrazol-3-yl]sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;2-(7-fluoro-5-pyridin-4-yl-2,3-dihydro-1H-inden-4-yl)-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide;2-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide;N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonyl-2-[5-(2-methyl-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[4-chloro-2,6-di(propan-2-yl)phenyl]-N-[1-ethyl-5-(3-methoxyoxetan-3-yl)pyrazol-3-yl]sulfonylacetamide;N-[1-ethyl-5-(3-methoxyoxetan-3-yl)pyrazol-3-yl]sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;2-(7-fluoro-5-pyridin-4-yl-2,3-dihydro-1H-inden-4-yl)-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide;2-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide;N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonyl-2-[5-(2-methyl-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]acetamide?
The IUPAC name of 2-[4-chloro-2,6-di(propan-2-yl)phenyl]-N-[1-ethyl-5-(3-methoxyoxetan-3-yl)pyrazol-3-yl]sulfonylacetamide;N-[1-ethyl-5-(3-methoxyoxetan-3-yl)pyrazol-3-yl]sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;2-(7-fluoro-5-pyridin-4-yl-2,3-dihydro-1H-inden-4-yl)-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide;2-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide;N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonyl-2-[5-(2-methyl-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]acetamide (CID 157475258) is 2-[4-chloro-2,6-di(propan-2-yl)phenyl]-N-[1-ethyl-5-(3-methoxyoxetan-3-yl)pyrazol-3-yl]sulfonylacetamide;N-[1-ethyl-5-(3-methoxyoxetan-3-yl)pyrazol-3-yl]sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;2-(7-fluoro-5-pyridin-4-yl-2,3-dihydro-1H-inden-4-yl)-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide;2-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide;N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonyl-2-[5-(2-methyl-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]acetamide.
What is the SMILES notation for 2-[4-chloro-2,6-di(propan-2-yl)phenyl]-N-[1-ethyl-5-(3-methoxyoxetan-3-yl)pyrazol-3-yl]sulfonylacetamide;N-[1-ethyl-5-(3-methoxyoxetan-3-yl)pyrazol-3-yl]sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;2-(7-fluoro-5-pyridin-4-yl-2,3-dihydro-1H-inden-4-yl)-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide;2-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide;N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonyl-2-[5-(2-methyl-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]acetamide?
The canonical SMILES for 2-[4-chloro-2,6-di(propan-2-yl)phenyl]-N-[1-ethyl-5-(3-methoxyoxetan-3-yl)pyrazol-3-yl]sulfonylacetamide;N-[1-ethyl-5-(3-methoxyoxetan-3-yl)pyrazol-3-yl]sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;2-(7-fluoro-5-pyridin-4-yl-2,3-dihydro-1H-inden-4-yl)-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide;2-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide;N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonyl-2-[5-(2-methyl-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]acetamide is CCn1nc(S(=O)(=O)NC(=O)Cc2c(C(C)C)cc(Cl)cc2C(C)C)cc1C1(OC)COC1.CCn1nc(S(=O)(=O)NC(=O)Cc2c(C(C)C)cc(F)cc2C(C)C)cc1C1(OC)COC1.COC1(c2cc(S(=O)(=O)NC(=O)Cc3c(-c4ccnc(C)c4)ccc4c3CCC4)nn2C(C)C)COC1.COC1(c2cc(S(=O)(=O)NC(=O)Cc3c(-c4ccncc4)cc(F)c4c3CCC4)nn2C(C)C)COC1.COC1(c2cc(S(=O)(=O)NC(=O)Cc3c4c(cc5c3CCC5)CCC4)nn2C(C)C)COC1.
What is the InChIKey of 2-[4-chloro-2,6-di(propan-2-yl)phenyl]-N-[1-ethyl-5-(3-methoxyoxetan-3-yl)pyrazol-3-yl]sulfonylacetamide;N-[1-ethyl-5-(3-methoxyoxetan-3-yl)pyrazol-3-yl]sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;2-(7-fluoro-5-pyridin-4-yl-2,3-dihydro-1H-inden-4-yl)-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide;2-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide;N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonyl-2-[5-(2-methyl-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]acetamide?
The InChIKey is BVMYKUXPEOFVAK-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H32N4O5S.C26H29FN4O5S.C24H31N3O5S.C23H32ClN3O5S.C23H32FN3O5S/c1-17(2)31-24(27(35-4)15-36-16-27)14-26(29-31)37(33,34)30-25(32)13-23-21-7-5-6-19(21)8-9-22(23)20-10-11-28-18(3)12-20;1-16(2)31-23(26(35-3)14-36-15-26)13-25(29-31)37(33,34)30-24(32)12-21-18-5-4-6-19(18)22(27)11-20(21)17-7-9-28-10-8-17;1-15(2)27-21(24(31-3)13-32-14-24)12-23(25-27)33(29,30)26-22(28)11-20-18-8-4-6-16(18)10-17-7-5-9-19(17)20;2*1-7-27-20(23(31-6)12-32-13-23)11-22(25-27)33(29,30)26-21(28)10-19-17(14(2)3)8-16(24)9-18(19)15(4)5/h8-12,14,17H,5-7,13,15-16H2,1-4H3,(H,30,32);7-11,13,16H,4-6,12,14-15H2,1-3H3,(H,30,32);10,12,15H,4-9,11,13-14H2,1-3H3,(H,26,28);2*8-9,11,14-15H,7,10,12-13H2,1-6H3,(H,26,28).
What are the key properties of 2-[4-chloro-2,6-di(propan-2-yl)phenyl]-N-[1-ethyl-5-(3-methoxyoxetan-3-yl)pyrazol-3-yl]sulfonylacetamide;N-[1-ethyl-5-(3-methoxyoxetan-3-yl)pyrazol-3-yl]sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;2-(7-fluoro-5-pyridin-4-yl-2,3-dihydro-1H-inden-4-yl)-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide;2-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide;N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonyl-2-[5-(2-methyl-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]acetamide?
2-[4-chloro-2,6-di(propan-2-yl)phenyl]-N-[1-ethyl-5-(3-methoxyoxetan-3-yl)pyrazol-3-yl]sulfonylacetamide;N-[1-ethyl-5-(3-methoxyoxetan-3-yl)pyrazol-3-yl]sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;2-(7-fluoro-5-pyridin-4-yl-2,3-dihydro-1H-inden-4-yl)-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide;2-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide;N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonyl-2-[5-(2-methyl-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]acetamide has a molecular weight of 2506.48 g/mol, XLogP of 15.61, 41 rotatable bonds, 5 hydrogen bond donors, and 37 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-chloro-2,6-di(propan-2-yl)phenyl]-N-[1-ethyl-5-(3-methoxyoxetan-3-yl)pyrazol-3-yl]sulfonylacetamide;N-[1-ethyl-5-(3-methoxyoxetan-3-yl)pyrazol-3-yl]sulfonyl-2-[4-fluoro-2,6-di(propan-2-yl)phenyl]acetamide;2-(7-fluoro-5-pyridin-4-yl-2,3-dihydro-1H-inden-4-yl)-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide;2-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonylacetamide;N-[5-(3-methoxyoxetan-3-yl)-1-propan-2-ylpyrazol-3-yl]sulfonyl-2-[5-(2-methyl-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]acetamide is sourced from PubChem (CID 157475258), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).